Lanean...
Key differences between apoC-III regulation and expression in intestine and liver
ApoC-III is a critical cardiovascular risk factor, and humans expressing null mutations in apoC-III are robustly protected from cardiovascular disease. Because of its critical role in elevating plasma lipids and CVD risk, hepatic apoC-III regulation has been studied at length. Considerably less is k...
Gorde:
| Argitaratua izan da: | Biochem Biophys Res Commun |
|---|---|
| Egile Nagusiak: | , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6069593/ https://ncbi.nlm.nih.gov/pubmed/28739253 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbrc.2017.07.116 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|